FTC says CVS, Cigna, and UnitedHealth abuse middleman role. The interior of a CVS pharmacy store is seen on Aug. 7, 2024 in Austin, Texas. Brandon Bell/Getty. Units of CVS ...

CVS Health, Cigna and UnitedHealth Group are demanding that FTC Chairwoman Lina Khan and two other commissioners recuse themselves from a lawsuit accusing the company and other drug middlemen of ...

CVS Health, UnitedHealth Group and Cigna sued the Federal Trade Commission, claiming the agency's case against drug middlemen over high insulin prices in the U.S. is unconstitutional.

CVS, Cigna and UnitedHealth are suing the Federal Trade Commission in a bid to block the agency’s lawsuit against their pharmacy benefit managers for allegedly inflating U.S. insulin prices.

The Federal Trade Commission on Friday filed an administrative complaint against the three largest pharmacy benefit managers and their affiliated group purchasing organizations, alleging they have ...

CVS, UnitedHealth and Cigna in October asked the FTC to disqualify Chair Linda Khan from the insulin suit, citing alleged bias against their pricing model.

Cigna’s Express Scripts sued the FTC on Tuesday over an interim report issued in July on PBMs, alleging it is “riddled with false statements” and seeking its retraction.

The US Federal Trade Commission sued units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. on Friday, accusing the drug middlemen of engaging in illegal rebate programs that drove up ...

One of the country’s biggest pharmacy-benefit managers, Cigna Group’sCI0.64%increase; green up pointing triangle Express Scripts, sued the Federal Trade Commission, demanding a retraction of a ...

Federal Trade Commission sues drug 'gatekeepers' over high insulin prices. ... Cigna Chief Legal Officer Andrea Nelson said the FTC was interested in scoring political points.

The Federal Trade Commission is planning to sue UnitedHealth, Cigna and CVS Health -- the three largest pharmacy-benefit managers -- over their tactics for negotiating prices for drugs including ...

The FTC said CVS Caremark, Cigna’s Express Scripts, and UnitedHealth’s OptumRx profit at the expense of patients forced to pay more for insulin.